Skip to main content
Top
Published in: Health Research Policy and Systems 1/2006

Open Access 01-12-2006 | Review

Improving the use of research evidence in guideline development: 2. Priority setting

Authors: Andrew D Oxman, Holger J Schünemann, Atle Fretheim

Published in: Health Research Policy and Systems | Issue 1/2006

Login to get access

Abstract

Background

The World Health Organization (WHO), like many other organisations around the world, has recognised the need to use more rigorous processes to ensure that health care recommendations are informed by the best available research evidence. This is the second of a series of 16 reviews that have been prepared as background for advice from the WHO Advisory Committee on Health Research to WHO on how to achieve this.

Objectives

We reviewed the literature on priority setting for health care guidelines, recommendations and technology assessments.

Methods

We searched PubMed and three databases of methodological studies for existing systematic reviews and relevant methodological research. We did not conduct systematic reviews ourselves. Our conclusions are based on the available evidence, consideration of what WHO and other organisations are doing and logical arguments.

Key questions and answers

There is little empirical evidence to guide the choice of criteria and processes for establishing priorities, but there are broad similarities in the criteria that are used by various organisations and practical arguments for setting priorities explicitly rather than implicitly,

What criteria should be used to establish priorities?

  • WHO has limited resources and capacity to develop recommendations. It should use these resources where it has the greatest chance of improving health, equity, and efficient use of healthcare resources.
  • We suggest the following criteria for establishing priorities for developing recommendations based on WHO's aims and strategic advantages:
  • Problems associated with a high burden of illness in low and middle-income countries, or new and emerging diseases.
  • No existing recommendations of good quality.
  • The feasibility of developing recommendations that will improve health outcomes, reduce inequities or reduce unnecessary costs if they are implemented.
  • Implementation is feasible, will not exhaustively use available resources, and barriers to change are not likely to be so high that they cannot be overcome.
  • Additional priorities for WHO include interventions that will likely require system changes and interventions where there might be a conflict in choices between individual and societal perspectives.

What processes should be used to agree on priorities?

  • The allocation of resources to the development of recommendations should be part of the routine budgeting process rather than a separate exercise.
  • Criteria for establishing priorities should be applied using a systematic and transparent process.
  • Because data to inform judgements are often lacking, unmeasured factors should also be considered – explicitly and transparently.
  • The process should include consultation with potential end users and other stakeholders, including the public, using well-constructed questions, and possibly using Delphi-like procedures.
  • Groups that include stakeholders and people with relevant types of expertise should make decisions. Group processes should ensure full participation by all members of the group.
  • The process used to select topics should be documented and open to inspection.

Should WHO have a centralised or decentralised process?

  • Both centralised and decentralised processes should be used. Decentralised processes can be considered as separate "tracks".
  • Separate tracks should be used for considering issues for specific areas, populations, conditions or concerns. The rationales for designating special tracks should be defined clearly; i.e. why they warrant special consideration.
  • Updating of guidelines could also be considered as a separate "track", taking account of issues such as the need for corrections and the availability of new evidence.
Literature
1.
go back to reference Fretheim A, Schünemann HJ, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 5. Group processes. Health Res Policy Syst. 2006 Fretheim A, Schünemann HJ, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 5. Group processes. Health Res Policy Syst. 2006
2.
go back to reference Oxman AD, Schünemann HJ, Fretheim A: Improving the Use of Research Evidence in Guideline Development: 8. Synthesis and presentation of evidence. Health Res Policy Syst. 2006 Oxman AD, Schünemann HJ, Fretheim A: Improving the Use of Research Evidence in Guideline Development: 8. Synthesis and presentation of evidence. Health Res Policy Syst. 2006
3.
go back to reference Global Programme on Evidence for Health Policy. Guidelines for WHO Guidelines. 2003, Geneva: World Health Organization, EIP/GPE/EQC/2003.1 Global Programme on Evidence for Health Policy. Guidelines for WHO Guidelines. 2003, Geneva: World Health Organization, EIP/GPE/EQC/2003.1
4.
go back to reference Moynihan R, Oxman AD, Lavis JN, Paulsen E: Evidence-Informed Health Policy: Using Research to Make Health Systems Healthier. A review of organizations that support the use of research evidence in developing guidelines, technology assessments, and health policy, for the WHO Advisory Committee on Health Research. 2006, Oslo: Norwegian Knowledge Centre for the Health Services Moynihan R, Oxman AD, Lavis JN, Paulsen E: Evidence-Informed Health Policy: Using Research to Make Health Systems Healthier. A review of organizations that support the use of research evidence in developing guidelines, technology assessments, and health policy, for the WHO Advisory Committee on Health Research. 2006, Oslo: Norwegian Knowledge Centre for the Health Services
5.
go back to reference Oxman AD, Fretheim A, Schünemann HJ: Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst. 2006 Oxman AD, Fretheim A, Schünemann HJ: Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst. 2006
9.
go back to reference Helou A, Perleth M, Schwartz FW: [Determining priorities in the development of medical guidelines. 1: Criteria, procedures and actors: a methodological review of international experiences] [Article in German]. Z Arztl Fortbild Qualitatssich. 2000, 94: 53-60.PubMed Helou A, Perleth M, Schwartz FW: [Determining priorities in the development of medical guidelines. 1: Criteria, procedures and actors: a methodological review of international experiences] [Article in German]. Z Arztl Fortbild Qualitatssich. 2000, 94: 53-60.PubMed
10.
go back to reference Battista RN, Hodge MJ: Setting priorities and selecting topics for clinical practice guidelines. CMAJ. 1995, 153: 1233-6.PubMedPubMedCentral Battista RN, Hodge MJ: Setting priorities and selecting topics for clinical practice guidelines. CMAJ. 1995, 153: 1233-6.PubMedPubMedCentral
12.
go back to reference Priority-Setting Group, Council on Health Care Technology, Institute of Medicine: National Priorities for the Assessment of Clinical Conditions and Medical Technologies. Report of a Pilot Study. 1990, Washington DC: National Academy Press Priority-Setting Group, Council on Health Care Technology, Institute of Medicine: National Priorities for the Assessment of Clinical Conditions and Medical Technologies. Report of a Pilot Study. 1990, Washington DC: National Academy Press
13.
go back to reference Committee on Priorities for Assessment and Reassessment of Health Care Technologies, Institute of Medicine: Setting Priorities for Health Technology Assessment. A Model Process. 1992, Washington DC: National Academy Press Committee on Priorities for Assessment and Reassessment of Health Care Technologies, Institute of Medicine: Setting Priorities for Health Technology Assessment. A Model Process. 1992, Washington DC: National Academy Press
14.
go back to reference Committee on Methods for Setting Priorities for Guidelines Development, Institute of Medicine: Setting Priorities for Clinical Practice Guidelines. 1995, Washington DC: National Academy Press Committee on Methods for Setting Priorities for Guidelines Development, Institute of Medicine: Setting Priorities for Clinical Practice Guidelines. 1995, Washington DC: National Academy Press
15.
go back to reference Oortwijn WJ: First Things First. Priority Setting for Health Technology Assessment. (PhD thesis). 2000, Leiden: The Netherlands Organisation for Applied Scientific Research (TNO) Prevention and Health Oortwijn WJ: First Things First. Priority Setting for Health Technology Assessment. (PhD thesis). 2000, Leiden: The Netherlands Organisation for Applied Scientific Research (TNO) Prevention and Health
16.
go back to reference McKinlay E, McLeod D, Dowell T, Howden-Chapman P: Clinical Practice Guidelines. A selective Literature Review. Prepared for the New Zealand Guidelines Group. 2001, Wellington: Wellington School of Medicine, University of Otago McKinlay E, McLeod D, Dowell T, Howden-Chapman P: Clinical Practice Guidelines. A selective Literature Review. Prepared for the New Zealand Guidelines Group. 2001, Wellington: Wellington School of Medicine, University of Otago
17.
18.
go back to reference Arnesen T, Kapiriri L: Can the value choices in DALYs influence global priority setting?. Health Policy. 2004, 70: 137-49. 10.1016/j.healthpol.2003.08.004.CrossRefPubMed Arnesen T, Kapiriri L: Can the value choices in DALYs influence global priority setting?. Health Policy. 2004, 70: 137-49. 10.1016/j.healthpol.2003.08.004.CrossRefPubMed
19.
go back to reference Wiseman V, Mooney G, Berry G, Tang KC: Involving the general public in priority setting: experiences from Australia. Soc Sci Med. 2004, 58: 1459-10.1016/S0277-9536(03)00305-8.CrossRef Wiseman V, Mooney G, Berry G, Tang KC: Involving the general public in priority setting: experiences from Australia. Soc Sci Med. 2004, 58: 1459-10.1016/S0277-9536(03)00305-8.CrossRef
Metadata
Title
Improving the use of research evidence in guideline development: 2. Priority setting
Authors
Andrew D Oxman
Holger J Schünemann
Atle Fretheim
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Health Research Policy and Systems / Issue 1/2006
Electronic ISSN: 1478-4505
DOI
https://doi.org/10.1186/1478-4505-4-14

Other articles of this Issue 1/2006

Health Research Policy and Systems 1/2006 Go to the issue